Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABIO
DateTimeSourceHeadlineSymbolCompany
12/02/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
12/02/20218:30AMGlobeNewswire Inc.ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19NASDAQ:ABIOARCA Biopharma Inc
11/23/20214:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABIOARCA Biopharma Inc
11/09/20214:15PMGlobeNewswire Inc.ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17thNASDAQ:ABIOARCA Biopharma Inc
11/02/20214:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
11/02/20214:15PMGlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
11/02/20214:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABIOARCA Biopharma Inc
10/28/20214:30PMGlobeNewswire Inc.ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety DataNASDAQ:ABIOARCA Biopharma Inc
09/16/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
09/16/20218:30AMGlobeNewswire Inc.ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19NASDAQ:ABIOARCA Biopharma Inc
08/16/20218:05AMGlobeNewswire Inc.ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18thNASDAQ:ABIOARCA Biopharma Inc
08/09/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
08/09/20218:00AMGlobeNewswire Inc.ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2NASDAQ:ABIOARCA Biopharma Inc
08/04/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
08/04/20214:15PMGlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
07/28/20218:00AMGlobeNewswire Inc.Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and ElectrophysiologyNASDAQ:ABIOARCA Biopharma Inc
07/13/20218:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
07/13/20218:00AMGlobeNewswire Inc.ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID...NASDAQ:ABIOARCA Biopharma Inc
07/09/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
07/09/20218:00AMGlobeNewswire Inc.ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13thNASDAQ:ABIOARCA Biopharma Inc
07/07/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
07/07/20218:00AMGlobeNewswire Inc.ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment AgreementNASDAQ:ABIOARCA Biopharma Inc
06/28/20214:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
06/10/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
05/11/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
05/11/20214:15PMGlobeNewswire Inc.ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
05/11/20214:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABIOARCA Biopharma Inc
05/06/20214:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABIOARCA Biopharma Inc
05/05/20214:05PMGlobeNewswire Inc.Christopher Graybill Joins ARCA as Vice President, Clinical DevelopmentNASDAQ:ABIOARCA Biopharma Inc
05/03/20215:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO